A planning model for the WHO-EPI vaccine distribution network in developing countries

被引:54
作者
Chen, Sheng-I [1 ]
Norman, Bryan A. [2 ]
Rajgopal, Jayant [2 ]
Assi, Tinam. [3 ]
Lee, Bruce Y. [4 ]
Brown, Shawn T. [5 ]
机构
[1] Nestle USA, Walnut Creek, CA 94596 USA
[2] Univ Pittsburgh, Dept Ind Engn, Pittsburgh, PA 15261 USA
[3] Univ Calif Los Angeles, Fielding Sch Publ Hlth, World Policy Anal Ctr, Los Angeles, CA 90095 USA
[4] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA
[5] Carnegie Mellon Univ, Pittsburgh Supercomp Ctr, Pittsburgh, PA 15213 USA
关键词
Supply chains; vaccine delivery; logistics; inventory; distribution networks; linear programming; capacity expansion; COMPUTATIONAL MODEL; SUPPLY CHAIN; SINGLE; IMPACT; VIALS;
D O I
10.1080/0740817X.2013.813094
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
In many developing countries, inefficiencies in the supply chain for the World Health Organization's Expanded Program on Immunization (EPI) vaccines are of grave concern; these inefficiencies result in thousands of people not being fully immunized and creates significant risk of disease epidemics. Thus, there is a great deal of interest in these countries in building tools to analyze and optimize how vaccines flow down several levels of the supply chain from manufacturers to vaccine recipients. This article develops a mathematical model for typical vaccine distribution networks in developing countries. This model has been successfully adapted for supply chains in three different countries (Niger, Thailand, and Vietnam), and its application to several issues of interest to public health administrators in developing countries is discussed.
引用
收藏
页码:853 / 865
页数:13
相关论文
共 29 条
[1]  
Adu FD, 1996, PUBLIC HEALTH, V110, P325, DOI 10.1016/S0033-3506(96)80003-5
[2]   Impact of changing the measles vaccine vial size on Niger's vaccine supply chain: a computational model [J].
Assi, Tina-Marie ;
Brown, Shawn T. ;
Djibo, Ali ;
Norman, Bryan A. ;
Rajgopal, Jayant ;
Welling, Joel S. ;
Chen, Sheng-I ;
Bailey, Rachel R. ;
Kone, Souleymane ;
Kenea, Hailu ;
Connor, Diana L. ;
Wateska, Angela R. ;
Jana, Anirban ;
Wisniewski, Stephen R. ;
Van Panhuis, Willem G. ;
Burke, Donald S. ;
Lee, Bruce Y. .
BMC PUBLIC HEALTH, 2011, 11
[3]  
Centers for Disease Control and Prevention, 2012, PNEUM VACC
[4]  
Cormier G, 1999, J OPER RES SOC, V50, P52, DOI 10.2307/3010388
[5]   Rotavirus vaccine introduction in the Americas: progress and lessons learned [J].
de Oliveira, Lucia Helena ;
Danovaro-Holliday, M. Carolina ;
Matus, Cuauhtemoc Ruiz ;
Andrus, Jon Kim .
EXPERT REVIEW OF VACCINES, 2008, 7 (03) :345-353
[6]   A linear programming model for allocating HIV prevention funds with state agencies: A pilot study [J].
Earnshaw S.R. ;
Hicks K. ;
Richter A. ;
Honeycutt A. .
Health Care Management Science, 2007, 10 (3) :239-252
[7]  
Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1
[8]   Emergency response to a smallpox attack: The case for mass vaccination [J].
Kaplan, EH ;
Craft, DL ;
Wein, LM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (16) :10935-10940
[9]   Vaccine Supply Chains Need To Be Better Funded And Strengthened, Or Lives Will Be At Risk [J].
Kaufmann, Judith R. ;
Miller, Roger ;
Cheyne, James .
HEALTH AFFAIRS, 2011, 30 (06) :1113-1121
[10]  
Lala Mrudula K, 2003, Indian Pediatr, V40, P311